1921
Volume 85, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

During May 4, 2007–February 29, 2008, the United States resettled 6,159 refugees from Tanzania. Refugees received pre-departure antimalarial treatment with sulfadoxine-pyrimethamine (SP), partially supervised (three/six doses) artemether-lumefantrine (AL), or fully supervised AL. Thirty-nine malaria cases were detected. Disease incidence was 15.5/1,000 in the SP group and 3.2/1,000 in the partially supervised AL group (relative change = –79%, 95% confidence interval = –56% to –90%). Incidence was 1.3/1,000 refugees in the fully supervised AL group (relative change = –92% compared with SP group; 95% confidence interval = –66% to –98%). Among 39 cases, 28 (72%) were in refugees < 15 years of age. Time between arrival and symptom onset (median = 14 days, range = 3–46 days) did not differ by group. Thirty-two (82%) persons were hospitalized, 4 (10%) had severe manifestations, and 9 (27%) had parasitemias > 5% (range = < 0.1–18%). Pre-departure presumptive treatment with an effective drug is associated with decreased disease among refugees.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.2011.11-0132
2011-10-01
2020-07-10
Loading full text...

Full text loading...

/deliver/fulltext/14761645/85/4/612.html?itemId=/content/journals/10.4269/ajtmh.2011.11-0132&mimeType=html&fmt=ahah

References

  1. US Department of Homeland Security, 2009. 2009 Yearbook of Immigration Statistics. Available at: http://www.dhs.gov/files/statistics/publications/yearbook.shtm. Accessed March 1, 2011.
    [Google Scholar]
  2. Boggild AK, Parise ME, Lewis LS, Kain KC, 2007. Atovaquone-proguanil: report from the CDC expert meeting on malaria chemoprophylaxis (II). Am J Trop Med Hyg 76: 208223.
    [Google Scholar]
  3. Green MD, Nettey H, Villalva Rojas O, Pamanivong C, Khounsaknalath L, Grande Ortiz M, Newton PN, Fernandez FM, Vongsack L, Manolin O, 2007. Use of refractometry and colorimetry as field methods to rapidly assess antimalarial drug quality. J Pharm Biomed Anal 43: 105110.[Crossref]
    [Google Scholar]
  4. Eriksen J, Mwankusye S, Mduma S, Veiga MI, Kitua A, Tomson G, Petzold MG, Swedberg G, Gustafsson LL, Warsame M, 2008. Antimalarial resistance and DHFR/DHPS genotypes of Plasmodium falciparum three years after introduction of sulfadoxine-pyrimethamine and amodiaquine in rural Tanzania. Trans R Soc Trop Med Hyg 102: 137142.[Crossref]
    [Google Scholar]
  5. Mugittu K, Abdulla S, Falk N, Masanja H, Felger I, Mshinda H, Beck HP, Genton B, 2005. Efficacy of sulfadoxine-pyrimethamine in Tanzania after two years as first-line drug for uncomplicated malaria: assessment protocol and implication for treatment policy strategies. Malar J 4: 55.[Crossref]
    [Google Scholar]
  6. World Health Organization, 2010. WHO List of Prequalified Medicinal Products. Available at: http://apps.who.int/prequal/. Accessed March 1, 2011.
    [Google Scholar]
  7. Makanga M, Premji Z, Falade C, Karbwang J, Mueller EA, Andriano K, Hunt P, De Palacios PI, 2006. Efficacy and safety of the six-dose regimen of artemether-lumefantrine in pediatrics with uncomplicated Plasmodium falciparum malaria: a pooled analysis of individual patient data. Am J Trop Med Hyg 74: 991998.
    [Google Scholar]
  8. Piola P, Fogg C, Bajunirwe F, Biraro S, Grandesso F, Ruzagira E, Babigumira J, Kigozi I, Kiguli J, Kyomuhendo J, Ferradini L, Taylor W, Checchi F, Guthmann JP, 2005. Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial. Lancet 365: 14671473.[Crossref]
    [Google Scholar]
  9. Novartis, 2004. Monograph: Coartem. Third edition. Available at: http://www.smi-voyage-sante.com/docs/KitsPaluComposants/Coartem_monographie.pdf. Accessed March 1, 2011.
    [Google Scholar]
  10. White NJ, van Vugt M, Ezzet F, 1999. Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine. Clin Pharmacokinet 37: 105125.[Crossref]
    [Google Scholar]
  11. Ahmed R, Bowen J, O'Donnell W, 2004. Cultural competence and language interpreter services in Minnesota: results of a needs assessment survey administered to physician members of the Minnesota Medical Association. Minn Med 87: 4042.
    [Google Scholar]
  12. Derose KP, Escarce JJ, Lurie N, 2007. Immigrants and health care: sources of vulnerability. Health Aff (Millwood) 26: 12581268.[Crossref]
    [Google Scholar]
  13. Garrett CR, Treichel CJ, Ohmans P, 1998. Barriers to health care for immigrants and nonimmigrants: a comparative study. Minn Med 81: 5255.
    [Google Scholar]
  14. Weiss R, 2005. Improving care for immigrants. Health Prog 86: 1112.
    [Google Scholar]
  15. Newman RD, Parise ME, Barber AM, Steketee RW, 2004. Malaria-related deaths among U.S. travelers, 1963–2001. Ann Intern Med 141: 547555.[Crossref]
    [Google Scholar]
  16. Collinet-Adler S, Stauffer WM, Boulware DR, Larsen KL, Rogers TB, Williams DN, 2007. Financial implications of refugee malaria: the impact of pre-departure presumptive treatment with anti-malarial drugs. Am J Trop Med Hyg 77: 458463.
    [Google Scholar]
  17. Martens P, Hall L, 2000. Malaria on the move: human population movement and malaria transmission. Emerg Infect Dis 6: 103109.[Crossref]
    [Google Scholar]
  18. Zucker JR, 1996. Changing patterns of autochthonous malaria transmission in the United States: a review of recent outbreaks. Emerg Infect Dis 2: 3743.[Crossref]
    [Google Scholar]
  19. Darsie RF, Ward RA, 2005. Identification and Geographical Distribution of the Mosquitoes of North America, North of Mexico. Gainesville, FL: University Press of Florida.
    [Google Scholar]
  20. Filler SJ, MacArthur JR, Parise M, Wirtz R, Eliades MJ, Dasilva A, Steketee R, 2006. Locally acquired mosquito-transmitted malaria: a guide for investigations in the United States. MMWR Recomm Rep 55: 19.
    [Google Scholar]
  21. Maroushek SR, Aguilar EF, Stauffer W, Abd-Alla MD, 2005. Malaria among refugee children at arrival in the United States. Pediatr Infect Dis J 24: 450452.[Crossref]
    [Google Scholar]
  22. Ndao M, Bandyayera E, Kokoskin E, Gyorkos TW, MacLean JD, Ward BJ, 2004. Comparison of blood smear, antigen detection, and nested-PCR methods for screening refugees from regions where malaria is endemic after a malaria outbreak in Quebec, Canada. J Clin Microbiol 42: 26942700.[Crossref]
    [Google Scholar]
  23. Stauffer WM, Newberry AM, Cartwright CP, Rosenblatt JE, Hanson KL, Sloan L, Tsukayama DT, Taylor C, Juni BA, 2006. Evaluation of malaria screening in newly arrived refugees to the United States by microscopy and rapid antigen capture enzyme assay. Pediatr Infect Dis J 25: 948950.[Crossref]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2011.11-0132
Loading
/content/journals/10.4269/ajtmh.2011.11-0132
Loading

Data & Media loading...

  • Received : 05 Mar 2011
  • Accepted : 17 May 2011
  • Published online : 01 Oct 2011
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error